Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction

Study Questions:

What is the safety and efficacy of aldosterone antagonists (aldo-I) in clinical practice in patients with systolic heart failure (HF)?